Table 4.
A summary of the analysis of the splice site, frameshift and no-stop mutations
| HGD exon | Short name | Nucleotide change | Protein change | CrypSkip prediction | BDGP splice sites prediction | Net2Gene splice sites prediction | Mutalyzer protein effect prediction | Effect |
|---|---|---|---|---|---|---|---|---|
| 01i | IVS1-1G>A | c.16-1G>A | p.(Tyr6_Gln29del) | 0.16 exon skipping strongly favoured | 1 alternative acceptor site | No acceptable acceptor sites above threshold | ||
| 3 | S59fs | c.175delA | p.Ser59Alafsx52 | – | – | – | Severely truncated protein 52 novel amino acids |
Frameshift |
| 5 | IVS5+1G>T | c.342+1G>T | Uncertain (p.Leu95_Ser114del)* | 0.42 cryptic splice site activation | 2 alternative donor sites | 2 alternative donor sites | No change in protein (if exon is skipped deletion of 20 amino acids) | Aberrant splicing |
| 7 | IVS7+2T>C | c.469+2T>C | p.Arg154SerfsX22 | 0.01 exon skipping strongly favoured | No alternative donor splice sites | No alternative donor splice sites | No change in protein | Exon skipping aberrant splicing |
| 8 | IVS8-1G>T (V157fs) | c.470-1_494del25 | p.Val157Glufsx11 or if exon skipped p.Pro 158Thr fsx25 | 0.12 exon skipping strongly favoured | Acceptor splice site is abolished by the deletion | One alternative acceptor site | If skipped, a severely truncated protein with novel 10 residues + stop or a truncated protein with novel 24 residues + stop | Exon skip and frameshift |
| 10 | D226PfsX7 | c.664_674dupGCCAATCCTCG | p.(Asp226Profs*7) | – | – | – | Severely truncated protein 7 novel amino acids |
Frameshift |
| 14 | K431fs | c.1282-1292del11 | p.Lys431Hisfsx52 | – | – | – | Truncated protein with novel 10 residues + stop | Deletion causing frameshift |
| 14 | X446ext | c.1336G>C | p.X446ArgxtX24 | – | – | – | Extended protein with additional 24 residues + stop | Extension |
DNA variant numbering is based on cDNA (NM_000187.3), +1 corresponding to the A of the ATG. Protein effect numbering is based on NP_000178.2